Marktgröße und Marktanteil von Medikamenten gegen opioidinduzierte Verstopfung bis 2025 – 2031
Opioid Induced Constipation Drugs Market Report Analysis
Opioid Induced Constipation Drugs Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- AstraZeneca plc.
- Mallinckrodt Pharmaceuticals
- Salix Pharmaceuticals Inc.
- Merck & Co Inc.
- Shionogi & Co Ltd.
- Ironwood Pharmaceutical Inc.
- Pfizer
- Progenics Pharmaceuticals Inc.
- Nektar Therapeutics
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Arzneimitteltyp
- Methylnaltrexonbromid
- Lubiproston
- Naloxegol
- Naldemedin
- Docusat-Natrium
- andere
By Verschreibungstyp
- verschreibungspflichtige Medikamente
- rezeptfreie Medikamente
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For